Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

It's yet another perk of these medications.

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...

According to the World Health Organization,19.8 million people died from cardiovascular diseases in 2022. And seniors—many of ...

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...